Q3 EPS Estimates for agilon health Boosted by William Blair

agilon health, inc. (NYSE:AGL) – Stock analysts at William Blair upped their Q3 2025 earnings per share estimates for shares of agilon health in a note issued to investors on Tuesday, May 6th. William Blair analyst R. Daniels now expects that the company will post earnings per share of ($0.08) for the quarter, up from their prior estimate of ($0.09). The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.23) EPS, Q3 2026 earnings at ($0.07) EPS and FY2026 earnings at ($0.13) EPS.

Other equities research analysts have also issued reports about the company. Barclays lifted their price objective on agilon health from $2.00 to $3.00 and gave the stock an “underweight” rating in a research report on Thursday. Sanford C. Bernstein raised agilon health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Royal Bank of Canada increased their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Stifel Nicolaus lifted their target price on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday, February 26th. Finally, Robert W. Baird reduced their price target on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $4.89.

agilon health Price Performance

Shares of agilon health stock opened at $2.87 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $1.19 billion, a PE ratio of -3.05 and a beta of 0.38. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The company’s fifty day simple moving average is $4.27 and its two-hundred day simple moving average is $3.19.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. agilon health’s revenue for the quarter was down 4.5% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.02) EPS.

Institutional Trading of agilon health

Institutional investors have recently made changes to their positions in the business. Capital International Investors lifted its stake in agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after purchasing an additional 9,346,295 shares in the last quarter. Millennium Management LLC boosted its position in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after buying an additional 4,706,357 shares during the period. Algert Global LLC grew its stake in agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after purchasing an additional 1,924,157 shares in the last quarter. CenterBook Partners LP purchased a new position in shares of agilon health during the first quarter valued at $8,315,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after purchasing an additional 1,498,524 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.